AC Immune SA revenue for the last year amounted to 17.58 M USD, the most of which — 16.47 M USD — came from its highest performing source at the moment, Therapeutic and Diagnostic Products, the year earlier bringing 4.12 M USD. The greatest contribution to the revenue figure was made by Switzerland — last year it brought AC Immune SA 16.47 M USD, and the year before that — 4.12 M USD.